CLNN

Clene Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth 7/10
  • Value 0/10
Clene sales and earnings growth
CLNN Growth
Good
  • Revenue Y/Y -72.09%
  • EPS Y/Y 20.79%
  • FCF Y/Y 6.01%
Clene gross and profit margin trends
CLNN Profitability
Low
  • Gross margin 82.80%
  • EPS margin -25009.70%
  • ROIC 5Y -111.52%
Clene net debt vs free cash flow
CLNN Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.9
  • Interest coverage -10.7

Clene stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks